Condition: Rhabdoid Tumor · Sponsor: Ono Pharmaceutical Co., Ltd.
Investigate the efficacy and safety of ONO-4538 for the treatment of rhabdoid Tumors
This description comes directly from the study's public registry record.
North America Clinical Trial Support Desk · +18665877745(Toll-Free) · clinical_trial@ono-pharma.com
International Clinical Trial Support Desk · +17162141777(Standard) · clinical_trial@ono-pharma.com
Always discuss trial participation with your own doctor first.
| Nagoya University Hospital | Nagoya, Aichi-ken, Japan | Recruiting |
| Hokkaido University Hospital | Sapporo, Hokkaido, Japan | Recruiting |
| Hyogo Prefectural Kobe Children's Hospital | Kobe, Hyōgo, Japan | Recruiting |
| Osaka City General Hospital | Osaka, Osaka, Japan | Recruiting |
| National Cancer Center Hospital | Chuo-ku, Tokyo, Japan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06622941